James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $574.87 ($5.8M) on 2026-04-09, disclosed to the SEC on 2026-04-10.
Scheduled sale ($5.8M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $574.87 | 560 | $322K | 5.6% |
| 2 | $575.53 | 1,956 | $1.1M | 19.5% |
| 3 | $576.63 | 1,586 | $915K | 15.8% |
| 4 | $577.77 | 1,617 | $934K | 16.2% |
| 5 | $578.52 | 1,139 | $659K | 11.4% |
| 6 | $579.75 | 1,224 |
| $710K |
| 12.3% |
| 7 | $580.64 | 1,756 | $1.0M | 17.6% |
| 8 | $582.30 | 162 | $94K | 1.6% |
| Total | $577.89 avg | 10,000 | $5.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |